Lung Cancer Therapeutics Market Size Worth USD 57.69 Billion in 2032 | Emergen Research
04 janv. 2024 07h45 HE
|
Emergen Research
Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global lung cancer therapeutics market size was USD 28.00 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
Asia Cervical Cancer Screening Markets, 2023-2028 with AstraZeneca, Hologic, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health Dominating
06 nov. 2023 04h03 HE
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global Lung Cancer Diagnostics Strategic Research Report 2023: Imaging Tests Segment and US Leads, Molecular Tests Category and Asia-Pacific to Witness Growth
27 oct. 2023 06h33 HE
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Lung Cancer Diagnostics...
Europe Cervical Cancer Screening Market Analysis & Forecasts Report 2023-2028: Pap Tests and HPV Testing Gain Popularity, Governments Play Vital Role in Expanding Services
23 oct. 2023 05h18 HE
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Europe Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Redefining Breast Cancer Screening in Europe: New Research Report Sheds Light on Future Directions
17 oct. 2023 08h48 HE
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In a world where breast cancer awareness is more critical than ever, a groundbreaking research report, titled "Europe Breast Cancer Screening Market, Size,...
Elucent Announces New Partnership With SurvivingBreastCancer.org
16 oct. 2023 17h02 HE
|
Elucent
EDEN PRAIRIE, Minn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Elucent Medical, a pioneering medical device company specializing in developing innovative solutions for sensitive cancer screening techniques...
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
13 oct. 2023 13h10 HE
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Biomerica Reports First Quarter 2024 Financial Results
13 oct. 2023 06h39 HE
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
26 sept. 2023 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...
Global Lung Cancer Screening Market Size and Forecast to 2030: The Cost Conundrum - Challenges Posed by High Lung Cancer Screening Test Expenses
19 sept. 2023 08h48 HE
|
Research and Markets
Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer and Small Cell Lung Cancer],...